What drives public acceptance of nanotechnology?
How do the risks and benefits of nanotechnology, as viewed by the public, compare with those associated with other technologies such as genetically modified organisms, stem cells, biotechnology and nuclear power? And when deciding to use a specific nanotechnology product, will consumers consider the risks, the benefits, or both? We report the first large-scale empirical analyses of these questions.
Currall
Steven C
SC
Faculty of Engineering Sciences, University College London, Gower Street, London WC1E 6BT, UK. scc@ucl.ac.uk
King
Eden B
EB
Lane
Neal
N
Madera
Juan
J
Turner
Stacey
S
D006801:Humans; D038622:Internationality; D049329:Nanostructures / Q000008:administration & dosage / Q000009:adverse effects*; D036103:Nanotechnology / Q000639:trends*; D011639:Public Opinion; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors